Aclaris Therapeuticsincis A Biopharmaceutical Company Focused On Developing Innovative Treatments For Immuno Inflammatory Conditionsoriginally Established As A Specialty Pharmaceutical Dermatology Companyaclaris Has Shifted Its Emphasis To Address Underserved Areas In Immunologythe Company Is Led By A Team With Extensive Experience In Dermatology And Immunologyincluding Co Founder Drneal Walker Aclaris Utilizes Its Proprietary Kinect Technology Platform To Explore The Kinomeenabling The Development Of Novel Small And Large Molecule Drugsparticularly Kinase Inhibitorsthe Company Is Advancing A Range Of Therapeutic Candidatesincluding Monoclonal And Bispecific Antibodieswith Notable Projects Like Ati 052Which Has Received U Sfda Ind Clearanceaclaris Also Operates Confluence Discovery Technologiesa Contract Research Organization That Collaborates With Pharmaceutical And Biotech Companies Across Various Therapeutic Areas
